Royal Bank of Canada reiterated their outperform rating on shares of Pyxis Oncology (NASDAQ:PYXS – Free Report) in a report ...

William Blair issued their FY2027 earnings per share estimates for shares of Pyxis Oncology in a report issued on Tuesday, ...

RBC Capital analyst Leonid Timashev maintained a Buy rating on Pyxis Oncology (PYXS – Research Report) on March 18 and set a price target of ...

In a report released today, Andy Hsieh from William Blair reiterated a Hold rating on Pyxis Oncology (PYXS – Research Report). The company’s ...

Catherine, Princess of Wales, is celebrating the life of British teen Liz Hatton, who recently died after being diagnosed with a fast-progressing and rare form of cancer. Hatton was diagnosed ...

A brave Birmingham schoolboy has been diagnosed with a rare cancer after a routine eye test revealed the wicked disease. Huge Aston Villa fan Lewis Jukes, just 10, was having issues with his vision ...

Marking Colorectal Cancer Awareness Month, TODAY’s Craig Melvin reports on the groundbreaking research from the Dana-Farber Cancer Institute that’s working to find cancer before it spreads.

BOSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced ...

Pyxis Oncology BOSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers ...

BOSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced that ...